N-terminal segment of proinsulin C-peptide active in insulin interaction/desaggregation
- PMID: 21094141
- DOI: 10.1016/j.bbrc.2010.11.058
N-terminal segment of proinsulin C-peptide active in insulin interaction/desaggregation
Abstract
Evidence has emerged that proinsulin C-peptide has at least three types of functional interactions in addition to its role during synthesis and secretion of insulin. Thus, C-peptide has been shown (i) to bind to cell membranes triggering G-protein-mediated intracellular signaling; (ii) to be internalized into cells and nuclei promoting transcription of rRNA and expression of particular genes; and (iii) to interact with peptides, including insulin, causing desaggregation of insulin oligomers like a chaperone, and with itself, causing homo-oligomers potentially capable of forming aggregates and deposits. In this work, we studied the insulin-C-peptide interactions by monitoring desaggregation and binding effects of C-peptide fragments on insulin. We find that the N-terminal segment of C-peptide harbors an interaction with insulin and that Glu11 appears to play a role in this action. We conclude that C-peptide fragments with this residue can mimic C-peptide in biophysical interactions with insulin, and that the insulin-interacting and membrane-interacting effects of C-peptide are distinct, ascribable to separate C-peptide segments, N- and C-terminally, respectively. The findings may have relevance to peptide effects in diabetic and healthy states.
Copyright © 2010 Elsevier Inc. All rights reserved.
Similar articles
-
Mass spectrometric characterization and activity of zinc-activated proinsulin C-peptide and C-peptide mutants.Analyst. 2010 Feb;135(2):278-88. doi: 10.1039/b917600d. Epub 2009 Dec 4. Analyst. 2010. PMID: 20098759
-
C-peptide binding to human cell membranes: importance of Glu27.Biochem Biophys Res Commun. 2001 Jun 1;284(1):94-8. doi: 10.1006/bbrc.2001.4917. Biochem Biophys Res Commun. 2001. PMID: 11374876
-
Molecular and cellular effects of C-peptide--new perspectives on an old peptide.Exp Diabesity Res. 2004 Jan-Mar;5(1):15-23. doi: 10.1080/15438600490424479. Exp Diabesity Res. 2004. PMID: 15198368 Free PMC article. Review.
-
Proinsulin C-peptide interaction with protein tyrosine phosphatase 1B demonstrated with a labeling reaction.Biochem Biophys Res Commun. 2009 Sep 11;387(1):31-5. doi: 10.1016/j.bbrc.2009.06.074. Epub 2009 Jun 18. Biochem Biophys Res Commun. 2009. PMID: 19540198
-
The structure, molecular interactions and bioactivities of proinsulin C-peptide correlate with a tripartite molecule.Biomol Concepts. 2014 May;5(2):109-18. doi: 10.1515/bmc-2014-0005. Biomol Concepts. 2014. PMID: 25372746 Review.
Cited by
-
Current strategies and findings in clinically relevant post-translational modification-specific proteomics.Expert Rev Proteomics. 2015 Jun;12(3):235-53. doi: 10.1586/14789450.2015.1042867. Epub 2015 May 8. Expert Rev Proteomics. 2015. PMID: 25955281 Free PMC article. Review.
-
C-Peptide as a Therapy for Type 1 Diabetes Mellitus.Biomedicines. 2021 Mar 8;9(3):270. doi: 10.3390/biomedicines9030270. Biomedicines. 2021. PMID: 33800470 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical